Automated dubbing’s rapid advancements propel immersive, cross-cultural storytelling, bridging language gaps through agile AI engines while sparking unprecedented opportunities in entertainment, education, and live-streaming realms worldwideNew Delhi, Jan. 17, 2025 (GLOBE NEWSWIRE) -- The global automated dubbing service market is expected to reach a valuation of US$ 218.03 million by 2033 from $132.50 million in 2024 at a CAGR of 5.69% over the forecast period 2025–2033. Today, several major studios are al ...

Core Message - Abacus Analytics' Usual, Customary, and Reasonable (UCR) Determination service has been awarded the "Peer Reviewed by HFMA" designation after a rigorous review process [1][3] Company Overview - Abacus Analytics provides medical billing experts to law firms, insurance carriers, and medical providers to determine the usual, customary, and reasonable value of medical services [2][5] - The company's methodology is based on reviewing full bill charges against similar medical providers' chargemaster rates in a geographic region [2] - Abacus Analytics' experts have over 15 years of industry experience in healthcare finance and access to a wealth of data to accurately value medical care across the country [5] Industry Context - The Healthcare Financial Management Association (HFMA) has over 126,000 members nationwide and provides guidance, education, and tools to finance professionals in various healthcare settings [4] - HFMA's Peer Review process is an objective, third-party evaluation of business solutions used in the healthcare workplace, assessing effectiveness, quality, usability, price, value, and customer and technical support [3][4] - The Peer Review panel includes current customers, prospects, and industry experts, ensuring a comprehensive assessment [3]

In a strategic move to enhance its supply chain and delivery efficiency, Walmart Inc. (WMT) has deepened its partnership with Symbotic Inc. (SYM) through a new agreement. Per the deal, Symbotic will buy Walmart's Advanced Systems and Robotics business, enhancing Walmart’s Accelerated Pickup and Delivery (APD) capabilities at its stores.WMT & SYM’s Deal in DetailThe deal aims to bring Symbotic’s AI-powered robotics platform into Walmart's operations to provide faster and more convenient shopping experiences ...

International Business Machines Corporation (IBM) has inked an agreement to acquire Applications Software Technology (“AST”) LLC, a global Oracle consultancy firm.  The transaction builds on IBM's previous acquisition of Accelalpha in 2024, further enhancing its capabilities to assist clients in deploying, managing and maximizing the value of Oracle cloud solutions. The transaction, subject to customary closing conditions and certain regulatory approvals, is expected to close in the first quarter of 2025.IB ...

FDA CRL Impact on Atara Biotherapeutics - Shares of Atara Biotherapeutics (ATRA) plunged 40.5% after the FDA issued a complete response letter (CRL) against the company's biologics license application (BLA) for tabelecleucel (tab-cel) [1] - The CRL was linked to observations from a routine pre-license inspection of a third-party manufacturing facility, with no issues raised regarding manufacturing process, clinical efficacy, or safety data [3] - The FDA did not request additional clinical studies to support Ebvallo's approval [3] Ebvallo's Market and Clinical Data - Tab-cel, marketed as Ebvallo in the EU, is a novel T-cell immunotherapy for EBV+ PTLD, a rare hematologic malignancy with high mortality rates [2] - The BLA submission was based on the pivotal phase III ALLELE study, which showed a statistically significant 50% objective response rate in EBV+ PTLD patients [4] Financial and Operational Implications - The CRL has delayed Ebvallo's U.S. market entry, resulting in lost revenue potential [7] - Atara is eligible for a $60 million milestone payment from Pierre Fabre upon FDA approval, which has also been delayed, impacting operational funding [8] - The company reported preliminary cash, cash equivalents, and short-term investments of approximately $43 million as of Dec 31, 2024 [9] Strategic Alternatives and Funding - Atara is exploring strategic alternatives, including acquisition, merger, reverse merger, or sale of assets, to advance its CAR-T assets [11] - The company has signed a non-binding term sheet with Redmile Group for up to $15 million in equity funding to support Ebvallo BLA approval efforts [10] - If additional funding is not secured by Q1 2025, Atara plans to halt all CAR-T activities and focus solely on Ebvallo's approval [10] Industry Comparison - In the past three months, Atara shares have lost 16.8%, compared to the industry's 12.2% decline [2] - Castle Biosciences (CSTL), CytomX Therapeutics (CTMX), and BioMarin Pharmaceutical (BMRN) are better-ranked stocks in the sector, each sporting a Zacks Rank 1 (Strong Buy) [12] - Castle Biosciences' shares have plunged 23.2% in the past three months, while CytomX Therapeutics and BioMarin Pharmaceutical have lost 28.2% and 12.6%, respectively [13][14][15]

LiveOne, Inc. (LVO) has surpassed 500,000 Tesla, Inc. (TSLA) users. Following an initial rollout to Tesla subscribers, the partnership is set to expand its reach starting this week. In December 2024, the company surpassed 450,000 Tesla users, including more than 100,000 free ad-supported users, who on average, spend more than 50 minutes of in-vehicle listening daily.The company anticipates to grow its user base to over 550,000 by Feb. 1, 2025, including the addition of more than 150,000 new ad-supported sub ...

Key TakeawaysApple shares will be in focus on Friday after recording their largest one-day drop since early August yesterday following news that the tech giant lost its position as China’s largest smartphone seller last year.The stock fell decisively below the lower trendline of an ascending triangle, raising the possibility of a significant breakdown.Investors should watch key support levels on Apple's chart around $218 and $207, while also monitoring important resistance levels near $235 and $250. Apple ( ...

Key TakeawaysJ.B. Hunt Transport Services missed fourth-quarter revenue and profit forecasts as volumes slumped.All of the big shipping firm's segments reported a decline in revenue in the fourth quarter.CEO Shelley Simpson said the freight industry continues to face a "challenging" environment. Shares of J.B. Hunt Transport Services (JBHT) tumbled 7% Friday, a day after the big shipping firm reported a drop in sales as volumes fell. The company reported fourth-quarter revenue tumbled 5% year-over-year to $ ...

PITTSBURGH, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Legend Senior Living, a national senior living provider operating 12 residences in Pennsylvania today, has assumed management of two senior living communities in the Pittsburgh area. The Waters of Wexford and The Waters of McMurray will operate under the new name The Province of Wexford and Ridgecrest of McMurray respectively. The Province of Wexford will continue to offer Independent Living, Assisted Living and Memory Care, while Ridgecrest of McMurray will off ...

Analyst’s Disclosure: I/we have a beneficial long position in the shares of ORANY either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. While this article may sound like financial advice, please observe that the author is not a CFA or in any way licensed to give financial advi ...